The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
This article has been corrected | View Correction

References

  • 1 Kessler RC , Adler L , Barkley R , Biederman J , Conners CK , Demler O , Faraone SV , Greenhill LL , Howes MJ , Secnik K , Spencer T , Ustun TB , Walters EE , Zaslavsky AM : The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006; 163:716–723 LinkGoogle Scholar
  • 2 Barkley RA , Fischer M , Smallish L , Fletcher K : Young adult outcome of hyperactive children: adaptive functioning in major life areas. J Am Acad Child Adolesc Psychiatry 2006; 45:192–202 Crossref, MedlineGoogle Scholar
  • 3 Biederman J , Monuteaux MC , Mick F , Spencer T , Wilens TE , Silva JM , Snyder LE , Faraone SV : Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006; 36:167–179 Crossref, MedlineGoogle Scholar
  • 4 Wilens TE , Biederman J , Mick E , Faraone SV , Spencer T : Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997; 185:475–482 Crossref, MedlineGoogle Scholar
  • 5 Spencer T , Biederman J , Wilens T , Doyle R , Surman C , Prince J , Mick E , Alcardi M , Herzig K , Faraone S : A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57:456–463 Crossref, MedlineGoogle Scholar
  • 6 Michelson D , Adler L , Spencer T , Reimherr FW , West SA , Allen AJ , Kelsey D , Wernicke J , Dietrich A , Milton D : Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003; 15:112–120 CrossrefGoogle Scholar
  • 7 Wolf LE , Wasserstein J : Adult ADHD: concluding thoughts. Ann NY Acad Sci 2001; 931:396–408 Crossref, MedlineGoogle Scholar
  • 8 Douglas VI : Cognitive control processes in attention-deficit/hyperactivity disorder, in Handbook of Disruptive Behavior Disorders. Edited by Quay HCHogan AE. New York, Kluwer Academic/Plenum Publishers, 1999, pp 105–138 Google Scholar
  • 9 Wilens TE , Spencer TJ , Biederman J : A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord 2002; 5:189–202 Crossref, MedlineGoogle Scholar
  • 10 Weiss M , Safren SA , Solanto MV , Hechtman L , Rostain AL , Ramsay JR , Murray C : Research forum on psychological treatment of adults with ADHD. J Atten Disord 2008; 11:642–651 Crossref, MedlineGoogle Scholar
  • 11 McDermott SPWilens TE: Cognitive therapy for adults with ADHD, in Attention Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Edited by Brown T. Washington, DC, American Psychiatric Press, 2000, pp 569–606 Google Scholar
  • 12 Hesslinger B , Tebartz van Elst L , Nyberg E , Dykierek P , Richter H , Berner M , Ebert I : Psychotherapy of attention deficit hyperactivity disorder in adults: a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 2002; 252:177–184 Crossref, MedlineGoogle Scholar
  • 13 Virta M , Vedenpaa A , Gronroos N , Chydenius E , Partinen M , Vataja R , Kaski M , Iivanainen M : Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants. J Atten Disord 2008; 12:218–226 Crossref, MedlineGoogle Scholar
  • 14 Rostain AL , Ramsay JR : A combined treatment approach for adults with ADHD: results of an open study of 43 patients. J Atten Disord 2006; 10:150–159 Crossref, MedlineGoogle Scholar
  • 15 Stevenson CS , Whitmont S , Bornholt L , Livesey D , Stevenson RJ : A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust NZ J Psychiatry 2002; 36:610–616 Crossref, MedlineGoogle Scholar
  • 16 Safren SA , Otto MW , Sprich S , Winett CL , Wilens TE , Biederman JJ : Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005; 43:831–842 Crossref, MedlineGoogle Scholar
  • 17 Roberts AH , Kewman DG , Mercier L , Hovell M : The power of nonspecific effects in healing: implications for psychosocial and biological treatments. Clin Psychol Rev 1993; 13:375–391 CrossrefGoogle Scholar
  • 18 Ilardi SS , Craighead WE : The role of nonspecific factors in cognitive-behavior therapy for depression. Clinical Psychology: Science and Practice 1994; 1:138–155 CrossrefGoogle Scholar
  • 19 Knouse LE , Sprich S , Cooper-Vince C , Safren SA : ADHD symptom profiles in medication-treated adults entering a psychosocial treatment program. Journal of ADHD and Related Disorders 2009; 1:34–47 MedlineGoogle Scholar
  • 20 Solanto MV , Marks DJ , Mitchell K , Wasserstein J , Kofman MD : Development of a new psychosocial treatment for adults with AD/HD. J Atten Disord 2008; 11:728–736 Crossref, MedlineGoogle Scholar
  • 21 Epstein JN , Johnson DE , Conners CK : Conners' Adult ADHD Diagnostic Interview for DSM-IV. North Tonawanda, NY, Multi-Health Systems, 2001 Google Scholar
  • 22 Conners CK , Erhardt D , Epstein JN , Parker JDA , Sitarenios G , Sparrow E : Self-ratings of ADHD symptoms in adults, I: factor structure and normative data. J Atten Disord 1999; 3:141–151 CrossrefGoogle Scholar
  • 23 Erhardt D , Epstein JN , Conners CK , Parker JDA , Sitarenios G : Self-ratings of ADHD symptoms in adults, II: reliability, validity, and diagnostic sensitivity. J Atten Disord 1999; 3:153–158 CrossrefGoogle Scholar
  • 24 Barkley RA , Murphy KR : Attention-Deficit Hyperactivity Disorder: A Clinical Workbook. New York, Guilford Press, 1998 Google Scholar
  • 25 First MB , Spitzer RL , Gibbon M , Williams JBW : Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, New York State Psychiatric Institute, Biometrics Research, November 2002 Google Scholar
  • 26 First MB , Gibbon M , Spitzer RL , Williams JBW , Benjamin LS : Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC, American Psychiatric Press, 1997 Google Scholar
  • 27 Tellegen A , Briggs PF : Old wine, new skins: grouping Wechsler subtests into new scales. J Consult Clin Psychol 1967; 31:499–506 CrossrefGoogle Scholar
  • 28 Adler LA , Spencer T , Biederman J : Adult ADHD Investigator Symptom Rating Scale–AISRS. Boston, Massachusetts General Hospital; and New York, New York University School of Medicine, 2003 Google Scholar
  • 29 Brown TE : Attention-Deficit Disorder Scales Manual. San Antonio, Tex, Psychological Corp, 1996 Google Scholar
  • 30 Roth RM , Isquith PK , Gioia GA : Behavior Rating Inventory of Executive Function–Adult Version (BRIEF-A). Lutz, Fla, Psychological Assessment Resources, 2005 Google Scholar
  • 31 Beck AT , Steer RA , Brown GK : Beck Depression Inventory, 2nd ed, Manual. San Antonio, Tex, Psychological Corp, 1996 Google Scholar
  • 32 Rosenberg M : Society and the Adolescent Self-Image. Princeton, NJ, Princeton University Press, 1965 CrossrefGoogle Scholar
  • 33 Shear MK , Vander Bilt J , Rucci P , Endicott J , Lydiard B , Otto MW , Pollack MH , Chandler L , Williams J , Ali A , Frank DM : Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety 2001; 13:166–178 Crossref, MedlineGoogle Scholar
  • 34 Waltz J , Addis ME , Koerner K , Jacobson NS : Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol 1993; 61:620–630 Crossref, MedlineGoogle Scholar
  • 35 Borkovec TD , Nau SD : Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972; 3:257–260 CrossrefGoogle Scholar
  • 36 Spencer TJ , Adler LA , McGough JJ , Muniz R , Jiang H , Pestreich L (Adult ADHD Research Group): Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61:1380–1387 Crossref, MedlineGoogle Scholar
  • 37 Medori R , Ramos-Quiroga A , Casas M , Kooij JJS , Niemela A , Trott G-E , Lee E , Buitelaar JK : A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphen­idate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2008; 63:981–989 Crossref, MedlineGoogle Scholar
  • 38 Weisler RH , Biederman J , Spencer TJ , Wilens TE , Faraone SV , Chrisman AK , Read SC , Tulloch SJ : Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 2006; 11:625–639 Crossref, MedlineGoogle Scholar